- Home
- SGLY vs GCTK Comparison
SGLY vs GCTK Comparison
Compare SGLY & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGLY | GCTK |
|---|---|---|
| Founded | 2001 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7M | 2.6M |
| IPO Year | 2008 | 2011 |
Fundamental Metrics
Financial Performance| Metric | SGLY | GCTK |
|---|---|---|
| Price | $0.29 | $0.53 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 159.6K | ★ 417.0K |
| Earning Date | 05-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.29 | N/A |
| EPS | N/A | ★ 2.65 |
| Revenue | ★ $1,813,193.00 | $589,462.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.20 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.18 | $0.29 |
| 52 Week High | $1.45 | $14.14 |
Technical Indicators
Market Signals| Indicator | SGLY | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 35.20 | 65.09 |
| Support Level | N/A | $0.43 |
| Resistance Level | $0.43 | $0.73 |
| Average True Range (ATR) | 0.03 | 0.06 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 57.01 | 75.07 |
Price Performance
Historical ComparisonAbout SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.